Senator Jeff Merkley @SenJeffMerkley
Reports that Pfizer CEO is cashing in on the pandemic at the same time they’re using taxpayer-funded tech for vaccine development are troubling. Doing this while also charging American taxpayers more per dose than other companies are charging demands accountability. — PolitiTweet.org
NPR @NPR
On the same day that Pfizer announced early good news about its coronavirus vaccine, its CEO sold $5.6 million wort… https://t.co/h4ysDSFbII